SERPINA1 and alpha 1-antitrypsin deficiency: When previously undescribed SERPINA1 variants are tentatively identified, full characterization of the patient’s medical history, lab values and genetic profile could be helpful in expanding the knowledge base of AATD and in providing guidance for selecting the best course of treatment.